Initia is proud to share that Dr. Anna Padoa presented groundbreaking clinical findings at the International Continence Society (ICS) 2024 Conference in Madrid, highlighting a novel, non-surgical approach to treating Stress Urinary Incontinence (SUI) with the MoreNova® shockwave therapy system.

A New Non-Surgical Solution for SUI

Stress Urinary Incontinence affects millions of women worldwide and is often associated with a decline in quality of life. Traditional treatment options have typically involved invasive surgical procedures or conservative therapies with limited long-term effectiveness.

The MoreNova® device introduces a specialized vaginal probe designed specifically for women’s health applications. This innovative technology uses low-intensity shockwaves to stimulate tissue regeneration, improve pelvic floor support, and enhance vascularization in targeted areas.

Dr. Padoa’s presentation demonstrated that this therapy offers:

• Significant symptom reduction, with measurable improvements in continence and patient-reported outcomes
  
• Enhanced quality of life, restoring confidence and daily function for women living with SUI
  
• Non-surgical, minimally invasive treatment, eliminating the risks and recovery time associated with conventional surgical approaches
  

Clinical Impact and Future Potential

These results underscore the potential of shockwave therapy as a game-changing treatment for SUI. For patients who are not candidates for surgery — or who prefer a non-invasive alternative — MoreNova® provides an effective, patient-friendly option backed by growing clinical evidence.

“This study represents a major step forward in women’s health,” said Dr. Padoa. “By offering a safe, non-surgical therapy for SUI, we can improve patient outcomes and expand treatment opportunities worldwide.”

Commitment to Advancing Women’s Health

At Initia, we remain dedicated to supporting research that drives innovation in women’s health. The success of this study reflects our mission to develop advanced, evidence-based solutions that empower physicians and improve quality of life for patients.

As global interest in non-invasive therapies continues to rise, the MoreNova® system is positioned at the forefront of regenerative treatment — offering a new standard of care for women with stress urinary incontinence.

Clinicians and healthcare providers interested in learning more about the therapy and its applications are invited to connect with our team to explore how MoreNova® can be integrated into clinical practice.